Skip to content
Review Open access

Juvenile Parkinson's disease: Symptom burden and treatment challenges

Aug 2026 · Journal of Parkinson's Disease · Vol 16, pp. 1351-1354 · 0 citations · 16 references
Medicine

Abstract

Juvenile Parkinson's disease (JPD) is a rare condition characterized by the onset of parkinsonian motor symptoms before the age of 21. Sixteen patients with JPD who presented to the Mayo Clinic between 1990-2020 were included. The median age of symptoms onset was 18.5 years, and six cases had pathogenic PRKN mutations. Resting tremor was the most frequent initial symptom (81.3%), and non-motor symptoms were notably common, including mild cognitive impairment (56.3%), anxiety (62.5%), and depression (56.3%). Levodopa responsiveness was suboptimal in 9 patients and 14 exhibited motor fluctuations. JPD demonstrates distinct clinical characteristics compared with early-onset and late-onset PD. Plain language summary A study of 16 patients who developed juvenile Parkinson's disease, analyzing symptoms, genetic causes, and treatment response Juvenile Parkinson's disease (JPD) is a rare condition with Parkinson's disease-like symptoms occurring in young people. We reviewed all patients diagnosed with Parkinson's disease at the Mayo Clinic between 1990 and 2020 and focused on those whose symptoms began before age 21, gathering information from their medical records about their symptoms, family history, genetic tests, and treatments. We identified 16 patients. A total of 63% had family members with Parkinson's disease, and half carried a genetic mutation linked to the disease. Most began showing symptoms around age 18, and the most common first sign was a resting tremor. Beyond movement, many also had memory or thinking difficulties (63%), anxiety (63%), and depression (56%). All received standard Parkinson's medications, which helped at first but became less effective over time, and many developed treatment-related abnormal movements. Four patients underwent a surgical procedure called deep brain stimulation, which helped control their symptoms. Juvenile Parkinson's disease has distinct genetic and clinical features and requires early recognition, genetic testing, and care tailored to each person.

Read PDF

Similar papers

Open access Oct 2026

Neuropsychiatric and Cognitive Symptom Evolution over the First Decade of Biomarker-Positive, Sporadic Parkinson's Disease.

BACKGROUND Parkinson's disease (PD) is frequently accompanied by neuropsychiatric symptoms (NPS), including cognitive impairment, which often emerge early and co-occur. Their long-term evolution remains incompletely characterized, particularly in biomarker-positive cohorts. OBJECTIVE The aim was to examine the evolut...

Izabelle Schoen, Jing Wang, Sharon X. Xie et al. · 0 citations
Review Open access Aug 2026

Symptom prevalence and pharmacological management of late-stage Parkinson's disease (LSPD): a cross-sectional, multinational survey.

Late-stage Parkinson's disease (LSPD) presents with disabling motor and non-motor symptoms, the latter becoming dominant in the late stage. There is limited information on LSPD. This study aimed to identify common symptoms and common drug treatments of LSPD. We conducted an online survey of physicians treating patients...

Christine Pallauf, Christiane Weck, Clemens Brandl et al. · 0 citations
Review Open access Sep 2026

Clinical trials in late-stage Parkinson's disease

Late-stage Parkinson's disease (LSPD) represents an under-recognized and under-studied phase of PD characterized by severe axial motor symptoms, high non-motor burden, cognitive impairment, functional dependence, and substantial caregiver involvement. Despite its major clinical and socioeconomic impact, LSPD seem to be...

Margherita Fabbri, Silvia Gallo, Tiago Machado et al. · 0 citations
Open access Oct 2026

The profile of patients diagnosed with Parkinson’s disease at the Charlotte Maxeke Johannesburg Academic Hospital

Background: Idiopathic Parkinson’s disease (IPD) is the second most common neurodegenerative disorder after Alzheimer’s disease, but data from Sub-Saharan Africa are scarce. This study describes the demographic and clinical characteristics of IPD patients at the Charlotte Maxeke Johannesburg Academic Hospital movement...

Itumeleng I. Lamola, Demetri G. A. Veliotes, A. Mochan · 0 citations
Review Open access Aug 2026

Young-onset Parkinsonʼs disease: a contemporary view of the problem

Background. Young-onset Parkinsonʼs disease (YOPD) is considered a clinically and genetically heterogeneous form of neurodegenerative pathology characterized by disease onset before the age of 50 years. Despite lower prevalence compared with classical Parkinsonʼs disease, YOPD is associated with substantial medical and...

I. Chernenko, Roman Chernenko · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.